Search
Kevin Jess
- Jan 16
- 3 min
WeHaveAFace USA and WeHaveAFace England and Wales Retire Charities
WeHaveAFace USA and WeHaveAFace England and Wales Retires Charities Florida, January16, 2023 – After almost fourteen years of providing...
279
Kevin Jess
- Jan 14
- 2 min
A letter to professional organizations: Project Change
Update to the Huntington's Disease community regarding Project Change: The need to change the diagnostic criteria in regards to HD is...
30
Kevin Jess
- Dec 22, 2022
- 3 min
A protective probiotic has been found for ALS, and also Huntington's Disease
According to a recent article published by the University of Montreal in Quebec, Canada, a probiotic bacterium called Lacticaseibacillus rha
236
Kevin Jess
- Dec 11, 2022
- 2 min
Tiny devices may help with motor function in neurodegenerative diseases
It may seem like science fiction but you just need to imagine for a moment tiny devices injected into a person's bloodstream guided by...
91
Kevin Jess
- Nov 23, 2022
- 2 min
UniQure announces AMT-130 trial to resume
Advancing AMT-130 for the treatment of Huntington’s disease In October 2022, the DSMB reviewed all available safety, biomarker and...
41
Kevin Jess
- Nov 17, 2022
- 2 min
InMed Pharmaceuticals Advances Neurodegenerative Disease Program-Huntington's Disease
Targeting neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s Identified two lead cannabinoid analog compounds...
54
Kevin Jess
- Oct 8, 2022
- 6 min
Teva begins Largest-Ever Trial to Collect Information about tardive dyskinesia
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the initiation of a...
48
Kevin Jess
- Sep 26, 2022
- 3 min
Teva Launches Website to Provide People Living With Huntington’s Disease Information on Chorea
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of the...
54
Kevin Jess
- Sep 21, 2022
- 5 min
Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial
September 20, 2022 at 7:30 AM EDT Single doses of WVE-003 appear generally safe and well-tolerated CSF mutant huntingtin (mHTT) protein...
72
Kevin Jess
- Aug 25, 2022
- 4 min
BrainVectis receives clearance to conduct Phase I/II clinical trial in France
National Agency for Safety of Medicines and Health Products (ANSM) and French Ethics Committee approve protocol for trial expected to...
69
